News, reviews and podcasts from annual scientific meetings and symposiums around the world.
A single-arm, phase II trial in men with PSMA-positive metastatic, castration-resistant prostate cancer (mCRPC) that…
This study evaluated niraparib, which is a poly (ADP-ribose) polymerase (PARP) inhibitor, in patients with metastatic…
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after…
Anticancer vaccines have gained a new lease of life with techniques to personalise them to…
Report on 3rd Annual Global Adolescent and Young Adult Cancer Congress, December 4-6th Sydney, Australia…
Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they…
Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk…
Substituting trastuzumab emtansine (T-DM1, Kadcyla) for adjuvant trastuzumab (Herceptin) in patients who had residual disease…
Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days…
Black women with the most common form of early breast cancer had worse outcomes than…